Harvard researchers began a clinical trial in December to determine whether a vaccine originally developed to treat tuberculosis (TB) can cure Type 1 diabetes.
“Most trials trying to reverse the disease are for new-onset diabetes,” said Denise L. Faustman, a Harvard Medical School professor who is helping to lead the study. “This is one of the first trials actually trying to manipulate the immune system in someone who has a long-standing disease.” More...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment